Your browser is no longer supported. Please, upgrade your browser.
ACAD ACADIA Pharmaceuticals Inc. monthly Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.97 Insider Own0.30% Shs Outstand144.31M Perf Week-0.87%
Market Cap4.27B Forward P/E- EPS next Y-1.21 Insider Trans0.00% Shs Float144.04M Perf Month13.23%
Income-267.90M PEG- EPS next Q-0.42 Inst Own97.20% Short Float9.20% Perf Quarter18.30%
Sales264.00M P/S16.19 EPS this Y-7.70% Inst Trans0.94% Short Ratio10.43 Perf Half Y27.35%
Book/sh2.69 P/B11.01 EPS next Y32.40% ROA-60.60% Target Price32.58 Perf Year114.72%
Cash/sh2.65 P/C11.19 EPS next 5Y28.10% ROE-71.00% 52W Range12.86 - 30.38 Perf YTD83.12%
Dividend- P/FCF- EPS past 5Y-34.30% ROI-51.90% 52W High-2.53% Beta2.74
Dividend %- Quick Ratio6.80 Sales past 5Y187.20% Gross Margin95.20% 52W Low130.25% ATR1.21
Employees477 Current Ratio6.80 Sales Q/Q45.70% Oper. Margin- RSI (14)63.86 Volatility3.41% 4.56%
OptionableYes Debt/Eq0.00 EPS Q/Q24.80% Profit Margin- Rel Volume0.82 Prev Close29.02
ShortableYes LT Debt/Eq0.00 EarningsJul 31 AMC Payout- Avg Volume1.27M Price29.61
Recom2.30 SMA2010.28% SMA5011.94% SMA20025.62% Volume1,039,537 Change2.03%
Jul-23-19Reiterated Needham Buy $40 → $34
Dec-10-18Initiated Canaccord Genuity Hold $23
Sep-21-18Upgrade Piper Jaffray Neutral → Overweight
Aug-09-18Reiterated Stifel Hold $17 → $14
Aug-07-18Initiated Stifel Hold $17
Aug-06-18Downgrade Piper Jaffray Overweight → Neutral
Oct-06-17Resumed Goldman Neutral
Nov-11-16Initiated Goldman Neutral
Nov-08-16Upgrade BofA/Merrill Neutral → Buy
Oct-19-16Resumed ROTH Capital Neutral
Oct-04-16Initiated Leerink Partners Mkt Perform $34
Jun-22-16Downgrade BofA/Merrill Buy → Neutral
May-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Mar-30-16Reiterated Piper Jaffray Overweight $39 → $44
Feb-08-16Initiated BofA/Merrill Buy $40
Jan-22-16Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Aug-16-19 10:42AM  Palatin's (PTN) to Report Q4 Earnings: What's in the Cards? Zacks
Aug-15-19 09:43AM  Top Ranked Momentum Stocks to Buy for August 15th Zacks
Aug-14-19 11:09AM  Top Ranked Momentum Stocks to Buy for August 14th Zacks
Aug-12-19 09:09AM  Top Ranked Momentum Stocks to Buy for August 12th Zacks
Aug-06-19 08:08AM  ACADIA Pharmaceuticals Inc. (ACAD) Shares March Higher, Can It Continue? Zacks
Aug-02-19 11:28AM  Edited Transcript of ACAD earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-01-19 12:06PM  Why Acadia Pharmaceuticals Stock Is Crushing It Today Motley Fool +16.64%
06:00AM  Acadia Pharmaceuticals Beats Expectations in Q2 Motley Fool
02:24AM  Acadia Pharmaceuticals (ACAD) Q2 2019 Earnings Call Transcript Motley Fool
Jul-31-19 06:55PM  Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  ACADIA Pharmaceuticals Reports Second Quarter 2019 Financial Results Business Wire
02:30PM  ACADIA Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
Jul-24-19 10:32AM  Will Acadia Pharmaceuticals (ACAD) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-23-19 11:38AM  Why Acadia Pharmaceuticals Is Tanking Today Motley Fool -14.44%
11:00AM  Are These 2 Beaten-Down Biotech Stocks Worth Buying? Motley Fool
07:26AM  The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation Benzinga
Jul-22-19 04:53PM  Acadia stock drops as schizophrenia drug doesn't pass clinical trial MarketWatch
04:44PM  Acadia's schizophrenia treatment misses late-stage main goal; shares fall 16% Reuters
04:14PM  Acadia's schizophrenia treatment fails to meet main goal of late-stage study Reuters
04:05PM  ACADIA Pharmaceuticals Announces Top-line Results from Phase 3 ENHANCE Trial of Pimavanserin as Adjunctive Treatment for Patients with Schizophrenia Business Wire
01:56PM  Acadia Falls Sharply in After-Hours Trading After Schizophrenia Drug Fails Study TheStreet.com
Jul-17-19 09:00AM  ACADIA Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019 Business Wire
Jul-11-19 06:36AM  Does ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) CEO Salary Reflect Performance? Simply Wall St.
Jun-25-19 08:50AM  New National Event Series "Parkinson's IQ + You" Launches to Educate and Empower Parkinson's Disease Patients and Care Partners PR Newswire
Jun-11-19 08:23PM  Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy? Insider Monkey
06:59AM  When Will ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Turn A Profit? Simply Wall St.
Jun-04-19 09:00AM  ACADIA Pharmaceuticals to Present at the Goldman Sachs 40th Annual Global Healthcare Conference Business Wire
May-18-19 11:00AM  ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major Depressive Disorder at the 2019 American Psychiatric Association Annual Meeting Business Wire
May-09-19 03:57AM  Edited Transcript of ACAD earnings conference call or presentation 1-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-08-19 03:30PM  Why Acadia Pharmaceuticals Stock Slumped in April Motley Fool
May-07-19 09:00AM  ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019 Business Wire
May-02-19 03:24AM  Acadia Pharmaceuticals (ACAD) Q1 2019 Earnings Call Transcript Motley Fool +7.78%
May-01-19 07:35PM  Acadia Pharmaceuticals (ACAD) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:29PM  Acadia: 1Q Earnings Snapshot Associated Press
04:05PM  ACADIA Pharmaceuticals Reports First Quarter 2019 Financial Results Business Wire
Apr-29-19 09:58PM  Were Hedge Funds Right About Flocking Into ACADIA Pharmaceuticals Inc. (ACAD)? Insider Monkey
Apr-26-19 06:10AM  Analysts point to potential Biogen M&A options after Alzheimer's failure American City Business Journals
Apr-25-19 09:00AM  ACADIA Pharmaceuticals Initiates Phase 3 CLARITY Program with Pimavanserin as Adjunctive Treatment for Major Depressive Disorder Business Wire
Apr-24-19 10:33AM  Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-19-19 09:11AM  Should ACADIA Pharmaceuticals (NASDAQ:ACAD) Be Disappointed With Their -30% Profit? Simply Wall St.
Apr-17-19 09:00AM  ACADIA Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019 Business Wire -8.58%
Apr-11-19 09:00AM  ACADIA Pharmaceuticals Supports Parkinsons Disease Awareness Month and World Parkinsons Day with Local Educational Initiatives and Community Events Across the Country Business Wire
Apr-02-19 09:00AM  ACADIA Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 9, 2019 Business Wire
Apr-01-19 09:00AM  ACADIA Pharmaceuticals Announces Promotion of Elena Ridloff, CFA to Executive Vice President, Chief Financial Officer Business Wire
Mar-29-19 07:20AM  Analysis: Positioning to Benefit within American Water Works, TripAdvisor, ACADIA Pharmaceuticals, Dril-Quip, Domtar, and Cara Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-28-19 12:14PM  U.S. Stocks Are Still Stuck Because Uncertainty Is Everywhere Barrons.com
07:54AM  The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO Benzinga
Mar-27-19 04:10PM  Positive Phase 2 Study Results of Trofinetide in Pediatric Rett Syndrome Published in Neurology, the Medical Journal of the American Academy of Neurology Business Wire
Mar-21-19 06:30AM  HLS Therapeutics Announces Q4 and Year-End 2018 Financial Results CNW Group
Mar-13-19 01:18PM  Is ACADIA Pharmaceuticals Inc.s (NASDAQ:ACAD) Liquidity Good Enough? Simply Wall St.
Mar-05-19 10:40PM  Edited Transcript of ACAD earnings conference call or presentation 26-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
02:36PM  Why Acadia Pharmaceuticals Stock Perked Up in February Motley Fool
Mar-04-19 09:00AM  ACADIA Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on March 11, 2019 Business Wire
Feb-27-19 09:30AM  3 Biotech Stocks Boasting Earnings Beats - and Healthy Outlooks TheStreet.com +8.36%
01:05AM  Acadia Pharmaceuticals Inc (ACAD) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-26-19 04:05PM  ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results Business Wire
01:28PM  Big Pharma faces the Senate in drug price hearings Yahoo Finance Video
Feb-21-19 09:00AM  ACADIA Pharmaceuticals to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019 Business Wire
Feb-15-19 04:08PM  What's in the Cards for Bausch Health (BHC) Q4 Earnings? Zacks +6.02%
Feb-14-19 12:58PM  5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings Zacks
Feb-13-19 08:15AM  New Research: Key Drivers of Growth for WPX Energy, ACADIA Pharmaceuticals, Lexicon Pharmaceuticals, MobileIron, Arrow Electronics, and Abeona Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-12-19 09:00AM  ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019 Business Wire
Feb-11-19 04:51PM  Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards? Zacks
03:58PM  Is a Disappointment in Store for Incyte (INCY) Q4 Earnings? Zacks
Feb-08-19 04:56PM  Tilray (TLRY) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-07-19 04:31PM  Exelixis (EXEL) to Report Q4 Earnings: What's in Store? Zacks
Jan-31-19 07:18PM  Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales? Zacks
Jan-30-19 10:02AM  Is a Beat in Store for Vertex (VRTX) This Earnings Season? Zacks
Jan-28-19 09:37AM  MacroGenics Up on Lifting of Partial Hold on Cancer Candidate Zacks
08:00AM  Today's Research Reports on Trending Tickers: Amicus Therapeutics and ACADIA Pharmaceuticals ACCESSWIRE
Jan-24-19 06:46AM  Will ACADIA Pharmaceuticals Continue to Surge Higher? Zacks
Jan-21-19 11:48AM  Does ACADIA Pharmaceuticals Inc.s (NASDAQ:ACAD) CEO Pay Compare Well With Peers? Simply Wall St.
Jan-17-19 10:18AM  Amgen's Postmenopausal Osteoporosis Drug Gets FDA Panel Nod Zacks
Jan-11-19 06:08PM  Glancy Prongay & Murray LLP Announces Investigation On Behalf Of ACADIA Pharmaceuticals Inc. Investors (ACAD) GlobeNewswire
Jan-10-19 07:00AM  Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE
Jan-08-19 03:38PM  Here's Why ACADIA Pharmaceuticals Dropped 15.2% in December Motley Fool
Dec-20-18 09:00AM  ACADIA Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019 Business Wire
Dec-16-18 11:37PM  Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy? Insider Monkey
Dec-13-18 10:46AM  Why ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Could Be Your Next Investment Simply Wall St.
Dec-03-18 08:10AM  Analysis: Positioning to Benefit within Symantec, ACADIA Pharmaceuticals, Novavax, BBX Capital, Paychex, and US Foods Holding Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +6.51%
Nov-30-18 04:05PM  ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire -5.32%
Nov-28-18 11:01AM  Here's Why Acadia Pharmaceuticals Is Soaring Motley Fool +20.76%
07:00AM  Todays Research Reports on Stocks to Watch: Loxo Oncology and ACADIA Pharmaceuticals ACCESSWIRE
Nov-27-18 09:20PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock Business Wire -12.64%
03:22PM  Why Acadia Pharmaceuticals Is Plummeting Motley Fool
07:32AM  The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial Benzinga
06:55AM  Today's Research Reports on Trending Tickers: Novavax and ACADIA Pharmaceuticals ACCESSWIRE
Nov-26-18 04:08PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire +5.13%
Nov-12-18 03:26PM  Edited Transcript of ACAD earnings conference call or presentation 6-Nov-18 10:00pm GMT Thomson Reuters StreetEvents
01:55PM  Analysts Expect Breakeven For ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Simply Wall St.
Nov-06-18 06:30PM  Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:25PM  Acadia: 3Q Earnings Snapshot Associated Press
04:05PM  ACADIA Pharmaceuticals Reports Third Quarter 2018 Financial Results Business Wire
Nov-01-18 08:00AM  Todays Research Reports on Stocks to Watch: Tonix Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE +14.78%
Oct-31-18 06:30AM  ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial of Pimavanserin for Adjunctive Treatment in Patients with Major Depressive Disorder (MDD) Business Wire -7.63%
Oct-30-18 10:33AM  Earnings Preview: Acadia Pharmaceuticals (ACAD) Q3 Earnings Expected to Decline Zacks
08:00AM  The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio Benzinga
Oct-29-18 04:35PM  ACADIA Pharmaceuticals Announces Executive Leadership Change Business Wire
Oct-26-18 08:00AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Array BioPharma ACCESSWIRE
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brege LauraDirectorJan 09Option Exercise2.1610,00021,60010,000Jan 11 04:32 PM
Brege LauraDirectorJan 09Sale20.0010,000200,0410Jan 11 04:32 PM
BAKER BROS. ADVISORS LPDirectorNov 30Buy17.0011,764,705199,999,98535,976,940Dec 04 05:00 PM
BAKER BROS. ADVISORS LPDirectorSep 20Buy18.701,210,77622,646,98924,798,117Sep 24 08:32 AM